1. Home
  2. CALM vs NRIX Comparison

CALM vs NRIX Comparison

Compare CALM & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cal-Maine Foods Inc.

CALM

Cal-Maine Foods Inc.

HOLD

Current Price

$61.19

Market Cap

3.1B

ML Signal

HOLD

NRIX

Nurix Therapeutics Inc.

HOLD

Current Price

$26.97

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CALM
NRIX
Founded
1957
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.6B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
CALM
NRIX
Price
$61.19
$26.97
Analyst Decision
Hold
Buy
Analyst Count
4
14
Target Price
★ $68.33
$34.50
AVG Volume (30 Days)
1.3M
★ 2.1M
Earning Date
09-30-2026
10-12-2026
Dividend Yield
★ 1.76%
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ 3.26
Revenue
★ $2,911,632,000.00
$76,987,000.00
Revenue This Year
N/A
$786.93
Revenue Next Year
$12.37
N/A
P/E Ratio
★ N/A
$8.32
Revenue Growth
N/A
★ 99.31
52 Week Low
$60.13
$11.67
52 Week High
$95.25
$28.23

Technical Indicators

Market Signals
Indicator
CALM
NRIX
Relative Strength Index (RSI) 33.81 67.26
Support Level $61.01 $24.61
Resistance Level $80.00 $28.23
Average True Range (ATR) 1.88 1.31
MACD 0.36 0.40
Stochastic Oscillator 17.40 98.89

Price Performance

Historical Comparison
CALM
NRIX

About CALM Cal-Maine Foods Inc.

Cal-Maine Foods Inc is an egg company in the U.S. Its shell egg portfolio includes conventional, specialty, cage-free, nutritionally enhanced, organic, brown, pasture-raised, and free-range eggs. The Company operates through the Conventional Shell Eggs, Specialty Shell Eggs and Prepared Foods segments, with Conventional Shell Eggs generating maximum revenue. The Conventional Shell Eggs segment consists mainly of the production, grading, packaging, marketing and distribution of conventional shell eggs, including Sunups and Sunny Meadow. The Company sells its products to grocery store chains, club stores, independent supermarkets, and foodservice distributors serving restaurants, convenience stores, healthcare and education facilities, and hotels throughout the U.S.

About NRIX Nurix Therapeutics Inc.

Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.

Share on Social Networks: